No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
COCO240517C25000
- 2.50
- +0.50+25.00%
15min DelayClose May 13 15:59 ET
2.50High2.50Low
2.50Open2.00Pre Close1 Volume336 Open Interest25.00Strike Price250.00Turnover0.00%IV-0.47%PremiumMay 17, 2024Expiry Date2.63Intrinsic Value100Multiplier3DDays to Expiry0.00Time Value100Contract SizeAmericanOptions Type--Delta--Gamma11.05Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- 1D
News
B&G Foods (BGS) Q1 Earnings & Sales Lag Estimates, Volumes Soft
AB InBev (BUD) Surpasses Earnings & Revenue Estimates in Q1
Zacks.com Featured Highlights Include SkyWest, Powell Industries, Minerals Technologies, The Vita Coco and Tenet Healthcare
The Vita Coco Company to Participate in the Goldman Sachs Global Staples Forum
PDF Version NEW YORK, May 06, 2024 (GLOBE NEWSWIRE) -- The Vita Coco Company, Inc. (NASDAQ: COCO) ("Vita Coco" or the "Company"), a leading high-growth platform of better-for-you beverage brand
Vita Coco Company (COCO) Upgraded to Strong Buy: Here's What You Should Know
Has ColgatePalmolive (CL) Outpaced Other Consumer Staples Stocks This Year?
Comments
CEOs of VITAS and Covenant Care laud the acquisition, emphasizing their shared mission and values. The move is seen as strategic, enabling Covenant Care to enhance community healthcare, while VITAS can build on Covenant Care's legacy of quality, patient-centered care.
Press Release: VITAS To Buy Hospice Assets of Covenant Care in Florida and Alabama 1
Despite Vita Coco's high P/E ratio, investors hold onto their stock expecting the company to continue defying market adversity. However, if the P/E falls in line with the growth outlook, this could disappoint. The high share price and future earnings predictions may not support this optimism for long, risking shareholders' investments and potential investors paying an unnecessary premium.
1
$Vita Coco(COCO.US$ rocketed
Vita Coco's Q4 results outperformed expectations, but its full-year revenue guidance was slightly disappointing. However, its strong cash profitability gives it an edge over competitors.
$Vita Coco(COCO.US$ who is drinking this
Read more